Michael Barbella, Managing Editor04.02.24
Inspire Medical Systems Inc. is about to lose one of its original board members.
Jerry C. Griffin, M.D.—who has served on the governing body for nearly as long as the firm has existed—is retiring at next month's annual stockholders meeting (scheduled for May 2).
“After sixteen years of service, we announce the retirement of Dr. Griffin from our Board of Directors. His contributions to our board and organization are innumerable and we are grateful for the dedication and direction he provided to our organization,” Inspire Medical Systems President/CEO Tim Herbert said. “I want to personally thank Jerry for his years at Inspire, his invaluable expertise, guidance and partnership contributed to Inspire growing from a startup to a medical device company with over 60,000 patients treated, 1,000 employees, and $600 million in annual revenue.”
Griffin has served on Inspire's board since 2008 and was one of the original board members, having joined Inspire prior to the initial Series A financing. He most recently served on the Nominating and Corporate Governance Committee. In December 2023, the Inspire Board appointed another physician and seasoned medical device executive—Myriam J. Curet, M.D.—to its board. Curet is currently executive vice president and chief medical officer at Intuitive Surgical.
Inspire Medical Systems develops and commercializes minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is reportedly the first and only U.S. Food and Drug Administration-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Jerry C. Griffin, M.D.—who has served on the governing body for nearly as long as the firm has existed—is retiring at next month's annual stockholders meeting (scheduled for May 2).
“After sixteen years of service, we announce the retirement of Dr. Griffin from our Board of Directors. His contributions to our board and organization are innumerable and we are grateful for the dedication and direction he provided to our organization,” Inspire Medical Systems President/CEO Tim Herbert said. “I want to personally thank Jerry for his years at Inspire, his invaluable expertise, guidance and partnership contributed to Inspire growing from a startup to a medical device company with over 60,000 patients treated, 1,000 employees, and $600 million in annual revenue.”
Griffin has served on Inspire's board since 2008 and was one of the original board members, having joined Inspire prior to the initial Series A financing. He most recently served on the Nominating and Corporate Governance Committee. In December 2023, the Inspire Board appointed another physician and seasoned medical device executive—Myriam J. Curet, M.D.—to its board. Curet is currently executive vice president and chief medical officer at Intuitive Surgical.
Inspire Medical Systems develops and commercializes minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is reportedly the first and only U.S. Food and Drug Administration-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.